Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong · Delayed Price · Currency is HKD 4.000
-0.200 (-4.76%)
Jun 16, 2026, 2:53 PM HKT
Wuhan YZY Biopharma Market Cap
Wuhan YZY Biopharma has a market cap or net worth of 775.4 million as of June 17, 2026. Its market cap has decreased by -5.44% in one year.
Market Cap
775.40M
Enterprise Value
806.21M
Revenue
74.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.00
Market Cap Chart
Since September 25, 2023, Wuhan YZY Biopharma's market cap has decreased from 3.09B to 775.40M, a decrease of -74.89%. That is a compound annual growth rate of -39.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 775.40M | -50.12% |
| Dec 31, 2025 | 1.55B | -3.14% |
| Dec 31, 2024 | 1.61B | -6.97% |
| Dec 29, 2023 | 1.73B | -44.13% |
| Sep 25, 2023 | 3.09B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.18B |
| Beijing Biostar Pharmaceuticals | 1.17B |
| Cutia Therapeutics | 1.17B |
| Cloudbreak Pharma | 1.10B |
| Sunho Biologics | 970.43M |
| Brii Biosciences | 743.46M |
| JW (Cayman) Therapeutics Co. | 698.14M |
| 3D Medicines | 676.28M |